Trial intelligence / Profile preview

IVIG for HGG in Lung Transplant Patients

NCT00115778Phase 2Completed

Sponsor
Columbia University
Start
Jun 2005
Primary completion
Aug 2009
Modality
Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of intravenous human immunoglobulin in hypogammaglobulinemia, sponsored by Columbia University. Started Jun 2005; status: completed.

02

Drugs

intravenous human immunoglobulin
03

Conditions

hypogammaglobulinemia

Beyond the preview

Go deeper on NCT00115778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00115778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call